Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Patients”

2,158 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,158 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT01856192
What this trial is testing

Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma

Who this might be right for
Ann Arbor Stage II Diffuse Large B-Cell LymphomaAnn Arbor Stage III Diffuse Large B-Cell LymphomaAnn Arbor Stage IV Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI) 349
Testing effectiveness (Phase 2)Study completedNCT00788892
What this trial is testing

Trial of CPX-351 in Newly Diagnosed Elderly AML Patients

Who this might be right for
Acute Myeloid Leukemia
Jazz Pharmaceuticals 126
Testing effectiveness (Phase 2)Study completedNCT00003211
What this trial is testing

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor

Who this might be right for
Brain and Central Nervous System Tumors
St. Jude Children's Research Hospital 94
Large-scale testing (Phase 3)Study completedNCT00689936
What this trial is testing

Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 1,623
Large-scale testing (Phase 3)UnknownNCT04083911
What this trial is testing

Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60

Who this might be right for
Acute Myeloid LeukemiaInduction Chemotherapy
The First Affiliated Hospital of Soochow University 50
Early research (Phase 1)Study completedNCT00095771
What this trial is testing

Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Not applicableNot Yet RecruitingNCT06483711
What this trial is testing

Reducing Barriers to Lifestyle Modification for Newly Diagnosed MASLD

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
Stanford University 50
Not applicableStudy completedNCT02332317
What this trial is testing

Early, Integrated, Specialized Palliative Rehabilitation

Who this might be right for
Advanced Cancer
Vejle Hospital 301
Not applicableLooking for participantsNCT06072690
What this trial is testing

Respiratory and Cardiovascular Alterations in Patients With Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease ModerateChronic Obstructive Pulmonary Disease SevereCardiovascular Diseases+1 more
Lithuanian University of Health Sciences 80
Testing effectiveness (Phase 2)Study completedNCT00082797
What this trial is testing

High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Eastern Cooperative Oncology Group 36
Early research (Phase 1)Looking for participantsNCT06634394
What this trial is testing

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Aptevo Therapeutics 39
Testing effectiveness (Phase 2)Study completedNCT00793572
What this trial is testing

Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma

Who this might be right for
Refractory Plasma Cell Myeloma
Fred Hutchinson Cancer Center 32
Testing effectiveness (Phase 2)Looking for participantsNCT07326566
What this trial is testing

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Who this might be right for
Glioblastoma (GBM)Newly Diagnosed GlioblastomaGBM+4 more
Black Diamond Therapeutics, Inc. 162
Early research (Phase 1)Study completedNCT00694837
What this trial is testing

Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma

Who this might be right for
Glioblastoma
Maastricht Radiation Oncology 6
Large-scale testing (Phase 3)Study completedNCT02667587
What this trial is testing

An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

Who this might be right for
Brain Neoplasms
Bristol-Myers Squibb 716
Early research (Phase 1)Study completedNCT01222221
What this trial is testing

Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Cancer Research UK 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT03395587
What this trial is testing

Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Heinrich-Heine University, Duesseldorf 136
Testing effectiveness (Phase 2)Looking for participantsNCT06579196
What this trial is testing

Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1

Who this might be right for
Non-small Cell Lung Cancer
University of Nebraska 45
Early research (Phase 1)Study completedNCT00089427
What this trial is testing

IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaOligoastrocytoma
INSYS Therapeutics Inc 24
Not applicableLooking for participantsNCT05000827
What this trial is testing

Dutch National Randomized Study: PSMA-PET/CT As a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients

Who this might be right for
Prostate Cancer MetastaticProstate CancerLymph Node Metastases
Canisius-Wilhelmina Hospital 706
Next Page